Finisar (FNSR) Tops Q4 EPS by 4c, Offers Q1 Gudiance

Finisar (NASDAQ: FNSR) reported Q4 EPS of $0.29, $0.04 better than the analyst estimate of $0.25. Revenue for the quarter came in at $318.8 million versus the consensus estimate of $317.38 million.

GUIDANCE:

Finisar sees Q1 2017 EPS of $0.27-$0.33, versus the consensus of $0.27. Finisar sees Q1 2017 revenue of $323-343 million, versus the consensus of $328 million.

For earnings history and earnings-related data on Finisar (FNSR) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Utah Medical Products (UTMD) Reports Q1 EPS of $1.10
• Allison Transmission (ALSN) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY24 Revenue Guidance